Does the FDA Think These Data Justify the First Full Approval of a COVID-19 Vaccine?

The U.S. Food and Drug Administration should have demanded adequate, controlled studies with long-term follow up, and made data publicly available, before granting full approval to COVID-19 vaccines, says BMJ Associate editor Peter Doshi.